Prometheus Laboratories | GenomeWeb

Prometheus Laboratories

VANCOUVER, BC – At the American Society for Mass Spectrometry annual meeting here this week a number of major vendors reiterated their commitment to moving their instruments into the clinic (

Shares of Rosetta Genomics got a major boost this week after the company effected a one-for-fifteen reverse stock split, and then announced it had launched a new microRNA-based diagnostic and had obtained Medicare coverage for its flagship cancer of unknown primary origin microRN

The University of California of Oakland has received US Patent No. 8,162,555, "Printing pins having selective wettability and method of making same." Printing pins are described that have an exterior surface and an interior surface that defines a lumen or capillary tract.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The US Supreme Court today invalidated two patents held by Prometheus Laboratories in a widely watched case for those involved in the personalized medicine field.

Rosetta Genomics last week said that it has avoided bankruptcy by coming up with money owed to one-time partner Prometheus Laboratories.
Rosetta said that it has paid Prometheus $650,000, plus accrued and unpaid interest, on a promissory note that was due Nov. 22.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Rosetta Genomics disclosed after the close of the market on Thursday that it has paid $650,000 it owed to Prometheus Laboratories.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.